CHEMBIO DIAGNOSTICS, INC. (CEMI) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Latin America	18.4	9.8	11.8	12.5
Europe & Middle East	5.2	9.9	6.5	4.9
Other	24.2	12.7	16.2	17.1
Total revenues [+]	47.8	32.5	34.5	34.6	24.0	17.9	24.3	27.6
Licensing						0.4	0.1	0.0
Products						13.7	21.9	25.9
Revenue growth [+]	47.3%	-5.8%	-0.3%	44.0%	34.4%	-26.3%	-12.3%	-6.4%
Latin America	87.2%	-16.7%	-5.9%
Europe & Middle East	-47.7%	52.4%	32.8%
Cost of goods sold	34.5	23.9	22.4	22.6	12.9	9.4	13.8	16.8
Gross profit	13.3	8.6	12.1	12.0	11.1	8.5	10.5	10.8
Gross margin	27.9%	26.5%	35.0%	34.6%	46.2%	47.3%	43.2%	39.1%
Selling, general and administrative	24.8	21.0	16.1	11.1	9.0	7.6	7.7	7.5
Other selling, general and administrative
Research and development	12.5	9.5	8.5	8.5	8.6	8.4	6.4	4.8
Other operating expenses	-2.6				-0.1
EBITDA [+]	-18.5	-19.3	-10.7	-6.7	-5.0	-6.4	-2.2	-0.8
EBITDA growth	-4.0%	80.1%	58.6%	34.9%	-22.3%	194.9%	169.0%	-150.1%
EBITDA margin	-38.6%	-59.3%	-31.0%	-19.5%	-20.8%	-36.0%	-9.0%	-2.9%
Depreciation	2.5	2.1	1.4	0.9	1.3	1.1	1.4	0.7
EBITA	-20.9	-21.4	-12.1	-7.6	-6.3	-7.6	-3.6	-1.6
EBITA margin	-43.8%	-65.8%	-35.1%	-22.1%	-26.1%	-42.4%	-14.7%	-5.6%
Amortization of intangibles	0.5	0.6	0.5
EBIT [+]	-21.4	-22.0	-12.6	-7.6	-6.3	-7.6	-3.6	-1.6
EBIT growth	-2.5%	74.1%	64.9%	21.8%	-17.1%	113.0%	129.3%	-253.1%
EBIT margin	-44.8%	-67.6%	-36.6%	-22.1%	-26.1%	-42.4%	-14.7%	-5.6%
Non-recurring items [+]	9.6	1.2	0.7	0.3	0.2
Asset impairment	2.6
Interest expense, net [+]	2.9	2.8	0.8	0.0	0.0	0.0	0.0	0.0
Interest expense	2.9	2.8	0.8				0.0
Interest income				0.0	0.0	0.0	0.0	0.0
Other income (expense), net [+]							0.0	0.0
Other non-ooperating expenses							0.0	0.0
Other							0.0	0.0
Pre-tax income	-34.0	-26.0	-14.2	-7.9	-6.5	-7.5	-3.6	-1.6
Income taxes	-0.1	-0.5	-0.5	-0.1	-0.1	5.8	-1.2	-0.4
Tax rate	0.2%	1.8%	3.5%	0.9%	1.4%		32.6%	26.6%
Net income	-33.9	-25.5	-13.7	-7.9	-6.4	-13.3	-2.4	-1.1
Net margin	-70.9%	-78.6%	-39.7%	-22.7%	-26.5%	-74.7%	-9.9%	-4.1%

Basic EPS [+]	($1.40)	($1.34)	($0.81)	($0.54)	($0.52)	($1.26)	($0.25)	($0.12)
Growth	4.3%	65.8%	48.0%	5.2%	-58.8%	404.6%	108.7%	-302.2%
Diluted EPS [+]	($1.40)	($1.34)	($0.81)	($0.54)	($0.52)	($1.26)	($0.25)	($0.12)
Growth	4.3%	65.8%	48.0%	5.2%	-58.8%	404.6%	108.7%	-314.0%

Shares outstanding (basic) [+]	24.3	19.1	17.0	14.4	12.3	10.6	9.6	9.5
Growth	27.3%	12.6%	17.5%	17.3%	15.8%	10.4%	1.0%	6.0%
Shares outstanding (diluted) [+]	24.3	19.1	17.0	14.4	12.3	10.6	9.6	9.5
Growth	27.3%	12.6%	17.5%	17.3%	15.8%	10.4%	1.0%	0.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.